Sironax

Private

BeijingHealthcare & Life Scienceshttps://www.sironax.com/

Last Round

Series B

Aug 2, 2022

Total Funding Raised

$300M

Company Overview

Sironax is a biotechnology company that develops innovative therapies for neurodegenerative, inflammatory, immunologic, and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologysmall-molecule therapeuticsdrug discoveryblood-brain barrierdrug delivery platformneurodegenerative diseasebrain delivery moduleBDMbiopharmaclinical-stage biotechSARM1 inhibitorRIPK1 inhibitorNAMPT activatordrug licensingCNS drug delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sironax Comps

Public and private peers based on sector, stage, and business model.

Sironax comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Sironax Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B	Aug 2, 2022
Series A	Aug 1, 2019
Series A	Jul 1, 2019

View all Funding Rounds

Sironax Investors

Notable investors and investment history

Sironax investors
Investor	Rounds
Longriver Investment Partners	Series B
Temasek	Series A, Series B
MSA Capital	Series B
ARCH Venture Partners	Series A, Series B
F-Prime Capital	Series A, Series B
Eight Roads Ventures	Series B, Series A
CBC Group	Series B

View all Investors

Sironax Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Sironax Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sironax's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing

Employee Range60

Year Founded2017

Last FundingAug 2, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.